Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00685_DB00900_nanopub.RAgKssOyZCC0yZbVvBjeVhSpnzZDLBnrM0ZTjr-KtA8YQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00685_DB00900 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00685_DB00900 label "DDI between Trovafloxacin and Didanosine - Didanosine may decrease the absorption of orally administered Trovafloxacin. The Didanosine formulation contains magnesium and aluminum ions that intefere with Trovafloxacin absorption. Administer Trovafloxacin 2 hours before or 6 hours after the Didanosine dose to minimize the interaction. This interaction is not observed with enteric coated Didanosine. [drugbank_resource:DB00685_DB00900]" assertion.
- drugbank_resource:DB00685_DB00900 identifier "drugbank_resource:DB00685_DB00900" assertion.
- drugbank_resource:DB00685_DB00900 title "DDI between Trovafloxacin and Didanosine - Didanosine may decrease the absorption of orally administered Trovafloxacin. The Didanosine formulation contains magnesium and aluminum ions that intefere with Trovafloxacin absorption. Administer Trovafloxacin 2 hours before or 6 hours after the Didanosine dose to minimize the interaction. This interaction is not observed with enteric coated Didanosine." assertion.
- drugbank:DB00685 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00685_DB00900 assertion.
- drugbank:DB00900 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00685_DB00900 assertion.